HCPLive

Cardiology
The MD Magazine Cardiology specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Conditions

Conferences

Latest CME

Sponsored

New Indication for Empagliflozin
Empagliflozin was approved to reduce heart and stroke risk in patients with diabetes.
Several studies have shown that patients with sleep apnea are more likely than others to develop atrial fibrillation, but recent information indicates that any type of disrupted sleep may indicate an elevated risk.
At AHA 2016, Poushali Mukherjea, PhD, Bristol-Myers Squibb, was proud to present with her team 12 abstracts bringing in new scientific data covering real world data and sub analyses from their pivotal trial ARISTOTLE.
It is reportedly safe to use tissue plasminogen activator, the clot busting medication, on patients who wake up with symptoms of stroke, according to a new study. Generally, tPA should be administered within 4.5 hours of symptom onset to be considered effective.
The MD Magazine editors rounded up the 10 best stories from November – did you read them all?
As the field of medical ethics continues to expand, its use can be seen in everything from general medical conditions to end of life considerations.
Following a stroke, the sooner a patient undergoes clot-busting endovascular thrombectomy, the better their outcomes are, in terms of severity of disability.
For men afflicted with type 2 diabetes and at high risk for heart attacks; however, relief might be found in an unlikely source – the erectile dysfunction drug Viagra (sildenafil).
By the time patients need a left ventricular assist device their condition has already worsened considerably. With the help of a combination of technology and medication there is some research to show that improvement is possible in many patients.

Most Popular in Cardiology

Recent Published Journal

@MDMagazine

$vacMongoViewPlus$ $vAR$